Phase 1 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your cancer must show signs of a specific protein called FAP (fibroblast activation protein), confirmed through a scan or clinical assessment.
- You must have a confirmed diagnosis of one of these cancer types: pancreatic cancer (adenocarcinoma), hormone receptor-positive/HER2-negative breast cancer, HER2-positive breast cancer, triple negative breast cancer, platinum-resistant or treatment-resistant ovarian cancer (including a type called ovarian carcinosarcoma), or certain other solid tumors including stomach cancer, colorectal cancer, esophageal cancer, or bile duct cancer (cholangiocarcinoma).
- You must have already received a certain number of prior cancer treatments depending on your cancer type and which part of the trial you are entering (confirm with trial site for the specific number that applies to your situation).
- You must be well enough to carry out light activity and care for yourself — scored 0 or 1 on a standard health scale used in cancer trials (confirm with trial site).
- Your kidneys must be working well enough, shown by a specific blood or urine test result (confirm with trial site).
Who may not be able to join:
- People who have active cancer that has spread to the brain or the lining around the brain and spine.
- People who have serious heart disease or heart problems.
- People whose heart rhythm test (ECG) shows a certain abnormality beyond a specific measurement level (confirm with trial site).
- People who have a blockage in their urinary tract that is not being treated.
- People who have previously had radiation therapy covering half or all of their body.
- People who have previously received a type of treatment where immune cells (T-cells) were modified and put back into the body, such as CAR-T therapy.
- People who are unable to lie still or cannot tolerate certain types of medical scans, including SPECT, PET, CT, or MRI scans.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Phase 1a: Percentage of Participants with Dose Limited Toxicity (DLT) Toxicities; Phase 1b: Objective Response Rate (ORR): Percentage of Participants with Best Response of Complete Response (CR) or Partial Response (PR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.